BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 23404300)

  • 21. Quality of life in Danish children and adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion or multiple daily injections.
    Birkebaek NH; Kristensen LJ; Mose AH; Thastum M;
    Diabetes Res Clin Pract; 2014 Dec; 106(3):474-80. PubMed ID: 25451903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation.
    Blair JC; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes DA; Gamble C;
    BMJ; 2019 Apr; 365():l1226. PubMed ID: 30944112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis.
    Jeitler K; Horvath K; Berghold A; Gratzer TW; Neeser K; Pieber TR; Siebenhofer A
    Diabetologia; 2008 Jun; 51(6):941-51. PubMed ID: 18351320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benefits of continuous subcutaneous insulin infusion (CSII) therapy in preschool children.
    Levy-Shraga Y; Lerner-Geva L; Modan-Moses D; Graph-Barel C; Mazor-Aronovitch K; Boyko V; Pinhas-Hamiel O
    Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):225-9. PubMed ID: 23329580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low uptake of continuous subcutaneous insulin infusion therapy in people with type 1 diabetes in Ireland: a retrospective cross-sectional study.
    Gajewska KA; Bennett K; Biesma R; Sreenan S
    BMC Endocr Disord; 2020 Jun; 20(1):92. PubMed ID: 32576284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin Pumps in Type 1 Diabetes with Mental Disorders: Real-Life Clinical Data Indicate Discrepancies to Recommendations.
    Prinz N; Bächle C; Becker M; Berger G; Galler A; Haberland H; Meusers M; Mirza J; Plener PL; von Sengbusch S; Thienelt M; Holl RW;
    Diabetes Technol Ther; 2016 Jan; 18(1):34-8. PubMed ID: 26451621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type 1 Diabetes and Long-Term Continuous Subcutaneous Insulin Infusion Therapy: A 10-Year Experience from Macedonia.
    Petrovski G; Zivkovic M; Stratrova SS; Todorova BJ
    Diabetes Technol Ther; 2017 Dec; 19(12):739-743. PubMed ID: 28976785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychosocial benefits of insulin pump therapy in children with diabetes type 1 and their families: The pumpkin multicenter randomized controlled trial.
    Mueller-Godeffroy E; Vonthein R; Ludwig-Seibold C; Heidtmann B; Boettcher C; Kramer M; Hessler N; Hilgard D; Lilienthal E; Ziegler A; Wagner VM;
    Pediatr Diabetes; 2018 Dec; 19(8):1471-1480. PubMed ID: 30302877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps.
    Potti LG; Haines ST
    J Am Pharm Assoc (2003); 2009; 49(1):e1-13; quiz e14-7. PubMed ID: 19196588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility of continuous subcutaneous insulin infusion and daily supplemental insulin glargine injection in children with type 1 diabetes.
    Alemzadeh R; Parton EA; Holzum MK
    Diabetes Technol Ther; 2009 Aug; 11(8):481-6. PubMed ID: 19698060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-term subcutaneous insulin infusion in diabetic children. Comparison with three daily insulin injections.
    Meschi F; Beccaria L; Vanini R; Szulc M; Chiumello G
    Acta Diabetol Lat; 1982; 19(4):371-5. PubMed ID: 6758461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dermatological complications of continuous subcutaneous insulin infusion in children and adolescents.
    Conwell LS; Pope E; Artiles AM; Mohanta A; Daneman A; Daneman D
    J Pediatr; 2008 May; 152(5):622-8. PubMed ID: 18410763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequency of dermatological side effects of continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes.
    Binder E; Lange O; Edlinger M; Meraner D; Abt D; Moser C; Steichen E; Hofer SE
    Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):260-4. PubMed ID: 25607337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indications for insulin pump therapy in different age groups: an analysis of 1,567 children and adolescents.
    Kapellen TM; Heidtmann B; Bachmann J; Ziegler R; Grabert M; Holl RW
    Diabet Med; 2007 Aug; 24(8):836-42. PubMed ID: 17650157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Current status of continuous subcutaneous insulin infusion and continuous glucose monitoring systems in the Community of Madrid].
    Arranz Martín A; Calle Pascual A; Del Cañizo Gómez FJ; González Albarrán O; Lisbona Gil A; Botella Serrano M; Pallardo Sánchez LF;
    Endocrinol Nutr; 2015 Apr; 62(4):171-9. PubMed ID: 25726367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous subcutaneous insulin infusion (CSII) pumps.
    Valla V
    Adv Exp Med Biol; 2012; 771():414-9. PubMed ID: 23393693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical factors affecting the perception of hypoglycemia in type 1 diabetes patients treated with personal insulin pumps.
    Matejko B; Grzanka M; Kieć-Wilk B; Małecki MT; Klupa T
    Ann Agric Environ Med; 2013; 20(1):152-4. PubMed ID: 23540230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin pump therapy in children with type 1 diabetes: analysis of data from the SWEET registry.
    Szypowska A; Schwandt A; Svensson J; Shalitin S; Cardona-Hernandez R; Forsander G; Sundberg F; De Beaufort C; Maahs D; Maffeis C; O'Riordan SM; Krisane ID; Scharf M; Castro S; Konstantinova M; Obermannova B; Casteels K; Gökşen D; Galhardo J; Kanaka-Gantenbein C; Rami-Merhar B; Madacsy L;
    Pediatr Diabetes; 2016 Oct; 17 Suppl 23():38-45. PubMed ID: 27417128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of Individual Basal Rate Profiles From Patient Characteristics in Type 1 Diabetes on Insulin Pump Therapy.
    Nauck MA; Kahle-Stephan M; Lindmeyer AM; Wenzel S; Meier JJ
    J Diabetes Sci Technol; 2021 Nov; 15(6):1273-1281. PubMed ID: 33251851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimizing Duration of Usage of Insulin Infusion Sets: Impact of Mechanical Stress on Infusion Sites and Identifying Individuals With IIS Issues.
    Walsh J; Heinemann L
    J Diabetes Sci Technol; 2024 Feb; ():19322968241233607. PubMed ID: 38379172
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.